15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 8 firms covering Bloomin Brands Inc, 1 rate it Buy or better, 6 sit at Hold, and 1 rate it Sell or worse, a hold consensus. Targets range widely, $6.00 to $12.00 (about 2.0x), a sign of real disagreement on valuation. The average target of $9.41 sits 2% below the current $9.59. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.15 next quarter toward $1.04 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS8 ratings
Hold
Strong Buy00%
Buy113%
Hold675%
Sell113%
Strong Sell00%
Based on 8 analysts giving stock ratings to Bloomin Brands Inc.
As of Sep, 1 of 8 firms rate BLMN a Buy (6 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
BLMN EPS & revenue forecast
EPS · NEXT QUARTER
$0.15
Range $0.06 – $0.26 · 12 analysts · -43% YoY
Next period, 12 analysts expect Bloomin Brands Inc to earn $0.15 a share (range $0.06 – $0.26), versus $0.26 a year earlier. Full-year consensus is $0.96, growing to $1.04 the year after.
REVENUE · NEXT QUARTER
$983.6M
Range $968.8M – $993.2M · 12 analysts · +1% YoY
Revenue is expected to reach $983.6M (range $968.8M – $993.2M), +0.9% year-over-year. Full-year consensus is $4.0B, rising to $4.0B next year.
Top analysts covering Bloomin Brands Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BLMN.
#1
Andrew Strelzik
BMO Capital · Rank #359
Hold
$7.00-27.0% to target
Overall win rate
36%
+ Follow
#2
Jeffrey Bernstein
Barclays
Hold
$9.00-6.2% to target
Coverage
—
+ Follow
#3
John Ivankoe
JP Morgan
Sell
$6.00-37.4% to target
Coverage
—
+ Follow
#4
Christine Cho
Goldman Sachs
Hold
$8.50-11.4% to target
Coverage
—
+ Follow
#5
Dennis Geiger
UBS
Hold
$9.00-6.2% to target
Coverage
—
+ Follow
BLMN stock forecast FAQ
What is BLMN's average 12-month price target?+
The 8 analysts with a live target average $9.41 for Bloomin Brands Inc over the next 12 months, ranging from a $12.00 high to a $6.00 low.
Is BLMN stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 8 analyst ratings, 1 are Buy or Strong Buy, 6 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for BLMN?+
The Street-high target is $12.00 (Piper Sandler), and the Street-low is $6.00 (JP Morgan). The average of all 8 active targets is $9.41.
How many Wall Street analysts cover BLMN?+
8 analysts have an active rating on Bloomin Brands Inc, and 8 firms carry a live 12-month price target.
Who is the most accurate analyst covering BLMN?+
Among analysts who currently cover BLMN, Andrew Strelzik of BMO Capital has the strongest overall Quantellect track record (Rank #359). Their current call is Hold with a $7.00 target.
What is Bloomin Brands Inc's projected EPS for next quarter?+
The consensus estimate is $0.15 per share (range $0.06 – $0.26) across 12 analysts. Full-year EPS is projected at $0.96, rising to $1.04 the following year.
How much revenue is Bloomin Brands Inc expected to report next quarter?+
Consensus revenue is $983.6M (range $968.8M – $993.2M). Full-year revenue is projected at $4.0B, growing to $4.0B next year.
Have analysts been upgrading or downgrading BLMN lately?+
As of Sep, 1 of 8 firms rate BLMN a Buy (6 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BLMN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.